Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ABUS - Arbutus Biopharma Corporation
1.4 M
LAST VALUE
-10.51%
2 YEAR CAGR
-8.43%
5 YEAR CAGR
8.64%
10 YEAR CAGR